PACS Group insider plans $6.4M stock sale
Form 144 shows Mark Hancock planning potential secondary sales of PACS Group, Inc. common stock, with prior sales detailed over the past three months.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PACS Group, Inc. (PACS) is named as the issuer in a Form 144 filing by Mark Hancock covering proposed sales of its common stock. The notice lists up to 144,318 shares of PACS common stock to be sold through Citigroup Global Markets Inc. on the NYSE, with an aggregate market value of $6,432,859.40 as of September 14, 2026.
The filing states that Hancock originally acquired 54,626,199 shares at the formation of the issuer on March 1, 2023 for cash, and details multiple prior sales of PACS common stock over the three months from June 15, 2026 to July 15, 2026, each with specified share counts and dollar amounts.
Key Figures
Key Terms
Rule 144 regulatory
Form 144 regulatory
aggregate market value financial
Securities To Be Sold financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for PACS Group, Inc. (PACS)?
Which broker is named for the PACS (PACS) stock sales in this Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.